Hutch News

Novel drug regimen reduces risks of graft-versus-host disease

Novel drug regimen reduces risks of graft-versus-host disease

From the Hill Group, Translational Science and Therapeutics Division in collaboration with Alfred Health and Monash University
Science SpotlightSeptember 08, 2025
Genetic Variability May Predict Severity of Side Effects From Methotrexate, A Common Chemotherapy Drug

Genetic Variability May Predict Severity of Side Effects From Methotrexate, A Common Chemotherapy Drug

DNA screening tool may be useful in tailoring treatments for cancer and other diseases
News ReleasesJune 25, 2001